Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 33058716

Relapse After Early-Stage, Favorable Hodgkin Lymphoma: Disease Characteristics and Outcomes With Conventional or High-Dose Chemotherapy.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2021 Jan 10
First author
Bröckelmann PJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2021 Jan 10;39(2):97-99. doi: 10.1200/JCO.20.02905.
    note
    Source null
    related pmid
    33275485
    relationship
    Comment in
  2. citation
    Cancer. 2021 Oct 1;127(19):3499. doi: 10.1002/cncr.33884.
    note
    Source null
    related pmid
    34478157
    relationship
    Comment in

Authors and identifiers

  1. name
    Bröckelmann PJ
    type
    Author
  2. name
    Müller H
    type
    Author
  3. name
    Guhl T
    type
    Author
  4. name
    Behringer K
    type
    Author
  5. name
    Fuchs M
    type
    Author
  6. name
    Moccia AA
    type
    Author
  7. name
    Rank A
    type
    Author
  8. name
    Soekler M
    type
    Author
  9. name
    Vieler T
    type
    Author
  10. name
    Pabst T
    type
    Author
  11. name
    Baues C
    type
    Author
  12. name
    von Tresckow B
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Bröckelmann PJ
    type
    Author
  2. name
    Müller H
    type
    Author
  3. name
    Guhl T
    type
    Author
  4. name
    Behringer K
    type
    Author
  5. name
    Fuchs M
    type
    Author
  6. name
    Moccia AA
    type
    Author
  7. name
    Rank A
    type
    Author
  8. name
    Soekler M
    type
    Author
  9. name
    Vieler T
    type
    Author
  10. name
    Pabst T
    type
    Author
  11. name
    Baues C
    type
    Author
  12. name
    von Tresckow B
    type
    Author
bibliography ids
  1. nci-bib-65a3111b8ea74ec4593f6982
book metadata
content sha256
2cd09910302703f50b059bde5cb1506b1626f23dd4411ad4c8bdb5f2a10cdb1d
document type
citation
dois
  1. 10.1200/JCO.20.00947
electronic publication date
display
2020 Oct 15
precision
day
year
2020
evidence scope
bibliographic_metadata_only
id
pubmed:33058716
immutable id
pubmed:33058716@2cd09910302703f50b059bde5cb1506b1626f23dd4411ad4c8bdb5f2a10cdb1d
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
2
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
107-115
volume
39
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2021 Jan 10;39(2):97-99. doi: 10.1200/JCO.20.02905.
    note
    Source null
    related pmid
    33275485
    relationship
    Comment in
  2. citation
    Cancer. 2021 Oct 1;127(19):3499. doi: 10.1002/cncr.33884.
    note
    Source null
    related pmid
    34478157
    relationship
    Comment in
outcomes validated
false
pmid
33058716
provenance
batch id
9bca82d1bba2b27adc79
provider
NCBI PubMed ESummary
record sha256
b736b9b78604ae173746dd4f810b3d504963b7151c6d275af0bee6a9c18c8edd
response sha256
c8a4853c65a45038af15f5ade3970763bfa121cf5c68bafcc52c3a06860d0211
retrieved at
2026-09-09T23:47:56.131551+00:00
publication date
display
2021 Jan 10
precision
day
year
2021
publication types
  1. Journal Article
  2. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/33058716/
title
Relapse After Early-Stage, Favorable Hodgkin Lymphoma: Disease Characteristics and Outcomes With Conventional or High-Dose Chemotherapy.

Preserved source evidence · Not medical advice